iiinova — where your digital self keeps evolving

Reposted by João Paulo Capela

Discover Journals @discover.springernature.com · 07/10/2026

An editorial in Discover Toxicology introduces the expertise and experience of the journal's editorial board, including the section editors who comprise its academic leadership, and invites researchers from the toxicology community to publish their next findings in this inclusive platform. #MedSky

bit.ly

Discover Toxicology, the future journal for your toxicology research

Discover Toxicology -

011

João Paulo Capela @jpcapela.bsky.social · 01/05/2026

Our latest work conducted with Methylphenidate, first-line to treat ADHD: "Repeated Oral Methylphenidate Administration Evokes Changes in Brain Plasticity Proteins in Juvenile Wistar Kyoto Rats: Evidence for Sex-Related Differences" Neurochem Res 51, 90 (2026). doi.org/10.1007/s110...

000

João Paulo Capela @jpcapela.bsky.social · 06/03/2026

Uma luz que nos deixou, mas continuará sempre a brilhar! Sentidas condolências à família e amigos.

010

João Paulo Capela @jpcapela.bsky.social · 26/02/2026

Discover Toxicology, published by Springer Nature, invites submissions of Reviews on hot topics in Toxicology. Full fee waiver if your article is submitted before the end of May. Please DM or contact me with any questions and request a formal invitation. link.springer.com/journal/44339

link.springer.com

Discover Toxicology

Discover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and society. ...

000

João Paulo Capela @jpcapela.bsky.social · 23/09/2025

As autoridades de saúde Portuguesas e Europeias estão a funcionar bem. Triste caso este da FDA nos EUA associar paracetamol com autismo, descredibilizando a ciência. Na EU e em Portugal acreditamos na Ciência! www.infarmed.pt/web/infarmed... #PharmSky #MedSky #ToxSky

infarmed.pt

Uso de paracetamol durante a gravidez mantém-se inalterado na UE

Infarmed

020

João Paulo Capela @jpcapela.bsky.social · 29/07/2025

Discover Toxicology, journal published by Springer Nature invites you to submit full-length or review articles on the “Toxicity of New Psychoactive Substances (NPS)”. Full fee waiver if your article is submitted by the end of October 2025. Please DM me for questions. link.springer.com/journal/44339

link.springer.com

Discover Toxicology

Discover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ...

120

Reposted by João Paulo Capela

Discover Journals @discover.springernature.com · 24/07/2025

Aligning with this year's World Environment Day theme “End Plastic Pollution," Discover Toxicology has launched a topical Collection: Toxicological Impacts of Microplastics in Freshwater Ecosystems. Submission Deadline: 31 Oct 2025!

bit.ly

Discover Toxicology

Discover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ...

001

Reposted by João Paulo Capela

Springer Nature @springernature.com · 09/06/2025

Have you taken part in Nature’s global survey of PhD students? We’ve had thousands of responses so far and would love to hear from you too. It should take no more than 15 mins and you can opt into a prize draw at the end. Survey closes 11 June. spklr.io/63320hAcC #PhDStudent

001

João Paulo Capela @jpcapela.bsky.social · 06/06/2025

The European Drug Report 2025 is out. Cannabis remains by far the most commonly consumed illicit drug in EU, which is followed by Cocaine. Synthetic cathinones, which I study, are increasingly integrated into EU drug market. www.euda.europa.eu/publications... #PharmSky #ToxSky #MedSky 🧪

euda.europa.eu

European Drug Report 2025: Trends and Developments | www.euda.europa.eu

The European Drug Report 2025: Trends and Developments presents the EUDA’s latest analysis of the drug situation in Europe.

010

João Paulo Capela @jpcapela.bsky.social · 06/06/2025

To support World Environment Day, the journal Discover Toxicology has selected four articles related to environmental toxicology that discuss human impact on the environment. See them at: communities.springernature.com/posts/world-... #PharmSky #ToxSky #MedSky 🧪

communities.springernature.com

World Environment Day 2025

Celebrating World Environment Day by showcasing our Discover Toxicology content on environmental toxicology and calling for papers

020

João Paulo Capela @jpcapela.bsky.social · 06/03/2025

I don’t think AI can help in reviewing, and more importantly manny journals do not allow it for some very good reasons. I rejected a paper recently because it was found that it was clearly AI written! However, using AI to fine tune English should be fine. #PharmSky #ToxSky #MedSky #NeuroSky 🧪

050

Reposted by João Paulo Capela

João Paulo Capela @jpcapela.bsky.social · 23/01/2025

I'm writing about amphetamine therapeutic use on obesity. I mean d-amphetamine or the racemic mixture, not other amphetamine-like drug. Can anyone tell if amphetamine is still approved in any country for obesity or weight loss? Thanks! #Amphetamine #PharmSky #ToxSky #MedSky #NeuroSky 🧪

112

João Paulo Capela @jpcapela.bsky.social · 23/01/2025

Clinical trials back then agreed in a minor, but statistically significant effect. The problems are the adverse events like cardiovascular and potential abuse.

100

João Paulo Capela @jpcapela.bsky.social · 23/01/2025

112

João Paulo Capela @jpcapela.bsky.social · 22/01/2025

Our latest on Melatonin in food supplements and Medicines in Portugal. Up to 2mg is considered a food supplement, above a medicine! Food supplements contain melatonin and plant extracts and should be more carefully studied. www.scielo.br/j/bjps/a/5t5... #PharmSky #ToxSky #MedSky #NeuroSky 🧪

scielo.br

051

João Paulo Capela @jpcapela.bsky.social · 16/01/2025

More one good news for science 🧪

0140

João Paulo Capela @jpcapela.bsky.social · 21/12/2024

Congratulations Vera for receiving this prestigious scientific career recognition prize! Muitos parabéns Vera por este merecido prémio de reconhecimento da tua carreira científica! 🤗🤗🤗🎉🎉🎉 🧪🔬 pt.linkedin.com/posts/vera-m...

pt.linkedin.com

Vera Marisa Costa no LinkedIn: É com grande orgulho que recebi, no dia 18 de dezembro de 2024, o Prémio…

É com grande orgulho que recebi, no dia 18 de dezembro de 2024, o Prémio Nunes Correa Verdades de Faria, atribuído pela Santa Casa da Misericórdia de Lisboa…

010

João Paulo Capela @jpcapela.bsky.social · 13/12/2024

For those interested in the anxiolytic effect of psychedelics I leave an interesting read. It seems interesting the possibility to dissociate the antianxiety effect of psychedelics from their hallucinogenic ones. #PharmSky #ToxSky #MedSky #NeuroSky 🧪 www.the-scientist.com/trippy-scien...

the-scientist.com

Trippy Science Unravels the Mystery of Psychedelics’ Antianxiety Effects

Researchers mimic the antianxiety effects of psychedelics by identifying and activating specific brain regions in an important step towards developing therapeutics that do not cause hallucinations.

1102

João Paulo Capela @jpcapela.bsky.social · 02/12/2024

That brings me back good memories, when I stayed until late hours I the lab✌️🧠🧪

160

João Paulo Capela @jpcapela.bsky.social · 27/11/2024

MDMA could be helpful in PSTD or other brain disorders. There should be clinical trials not only showing effectiveness but also safety, not only in the short but also in the long term. Caution is required due to the potential neurotoxicity and hepatotoxic actions of MDMA and it’s metabolites. 🧪

3100

João Paulo Capela @jpcapela.bsky.social · 25/11/2024

Concordo plenamente com a hipocrisia social. A nível universitário, por exemplo, há muita publicidade e patrocínios de bebidas alcoólicas, que a meu ver deviam ser repensados a favor da saúde pública.

000

João Paulo Capela @jpcapela.bsky.social · 23/11/2024

Mais uma investigadora de renome a dizer o óbvio! O financiamento da FCT no próxima OE vai baixar e seguramente no ano seguinte será igual. Se já estávamos com um nível baixo de financiamento da FCT, vamos ficar ainda pior!

000

João Paulo Capela @jpcapela.bsky.social · 22/11/2024

“For scientists the network is starting to look like home.” Strongly agree. I never had so many scientist interacting with my posts like I do now in Bluesky. #PharmSky #ToxSky #MedSky #NeuroSky 🧪 www.science.org/content/arti...

science.org

Like ‘old Twitter’: The scientific community finds a new home on Bluesky

After recent changes to Elon Musk’s X, a gradual migration turns into a stampede

26913

João Paulo Capela @jpcapela.bsky.social · 21/11/2024

Thanks for your interest. Bit amphetamine and methylphenidate are used in ADHD. So in controlled doses and settings they can be therapeutically useful. The major problem with these two drugs are cardiovascular, and trials reveal no major adverse effects that could undermine its use.

200

João Paulo Capela @jpcapela.bsky.social · 21/11/2024

I understand your concerns regarding the cardiovascular adverse effects, which no doubt should be given attention. The clinical trails did not show that adverse effects under control doses and settings were a problem. They did reveal mixed results, some improved others detailed no improvement.

000

João Paulo Capela @jpcapela.bsky.social · 21/11/2024

Thanks for your interest in our work. In fact regarding the brain it makes sense the use of stimulants for this neurological disorders. In particular methylphenidate, that is used to treat ADHD, has been given more attention for stroke or TBI.

100

João Paulo Capela @jpcapela.bsky.social · 21/11/2024

Muitos parabéns por estale excelente programa, que muito aprecio ouvir.

110

João Paulo Capela @jpcapela.bsky.social · 19/11/2024

Hi! Can you place me in the starter pack Pharmacy and Pharmacology? Thanks

010

João Paulo Capela @jpcapela.bsky.social · 15/11/2024

New Open Access Journal from Springer Nature: Discover Toxicology. I'm a Section Editor and invite you to take a look and see if it fits within your research area. link.springer.com/journal/44339

link.springer.com

Discover Toxicology

Discover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ...

290